| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.277 | 18.467 | 27.202 | 39.037 | 38.158 |
| Total Income - EUR | - | - | - | - | - | 5.277 | 18.467 | 27.202 | 39.037 | 38.742 |
| Total Expenses - EUR | - | - | - | - | - | 4.900 | 5.497 | 4.142 | 12.427 | 16.805 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 377 | 12.970 | 23.059 | 26.610 | 21.937 |
| Net Profit/Loss - EUR | - | - | - | - | - | 228 | 12.455 | 22.483 | 26.278 | 20.798 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Negogyn Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 8 | 776 | 533 | 1.713 | 925 |
| Current Assets | - | - | - | - | - | 4.613 | 11.951 | 23.364 | 32.405 | 25.532 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 51 | 5.573 | 16.007 | 620 | 19.942 |
| Cash | - | - | - | - | - | 4.562 | 6.377 | 7.357 | 31.785 | 5.590 |
| Shareholders Funds | - | - | - | - | - | 270 | 12.497 | 23.075 | 33.408 | 20.839 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 4.351 | 230 | 823 | 710 | 5.618 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Negogyn Medical S.r.l.